摘要 |
<p>The present invention discloses the use of 5-HT2B agonists or positive allosteric modulators (enhancers) such as paroxetine or BW-723C86 in the treatment of various CNS, affective, behavioral, migraine or feeding disorders, and in particular in depression.</p> |